UBS Lux Equity Fund Biotech USD vs Storebrand Grön Obligation A SEK

UBS Lux Equity Fund Biotech USD vs Storebrand Grön Obligation A SEK

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

2. Storebrand Grön Obligation A SEK

  • Security

    Storebrand Grön Obligation A SEK

  • Fee

    0.31%

  • ISIN

    SE0006763967

  • Holdings

    4

  • Number of owning funds

    1

Fund Holdings

We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with Storebrand Grön Obligation A SEK, we have 5 holdings where Stadshypotek is the largest holding (3.57), followed by Jernhusen (1.57) and Region Skåne (1.36).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Storebrand Grön Obligation A SEK.

UBS Lux Equity Fund Biotech USD Storebrand Grön Obligation A SEK
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Stadshypotek AB
Sweden
3.57 %
2. Moderna Inc
9.21 %
2. Jernhusen AB
Sweden
1.57 %
3. Vertex Pharmaceuticals Inc
8.44 %
3. Region Skåne
Sweden
1.36 %
4. Alnylam Pharmaceuticals Inc
8.08 %
4. Ziklo Bank AB
Sweden
1.35 %
5. AbbVie Inc
USA
4.91 %
-
6. Gilead Sciences Inc
USA
4.66 %
-
7. Amgen Inc
USA
4.43 %
-
8. BioNTech SE
4.13 %
-
9. Karuna Therapeutics Inc
3.75 %
-

The list of fund holdings was last updated on July 25, 2025.